Meanwhile, we found that PLAU, the crucial downstream gene of JPX, was also capable of regulating the aberrant epithelial–immune interaction in HNSCC by binding to its receptor PLAUR on immune cells. Here, JPX is linked to head and neck squamous cell carcinoma.